Compositions comprising an agonist of 5-hydroxytryptamine (5-ht) receptor subtype 2a, 2b or 2c

• 1. 5-HT_2C受体激动剂和组合物及使用方法 [P] . 中国专利： CN107873030B . 2021.03.19
• 2. 5-HT_2C受体激动剂和组合物及使用方法 [P] . 中国专利： CN108137508B . 2021.08.27
• 3. Compositions comprising an agonist of 5-hydroxytryptamine (5-ht) receptor subtype 3 [P] . GB202109023D0 . 2021-08-04

  机译： 包含5-羟基对氨基（5-HT）受体亚型3的激动剂的组合物

• 4. HIGHLY SELECTIVE 5-HT(2C) RECEPTOR AGONISTS HAVING ANTAGONIST ACTIVITY AT THE 5-HT(2B) RECEPTOR [P] . 欧洲知识产权局专利： EP2531485B1 . 2019-04-24

  机译： 具有高度选择性的5-HT（2C）受体激动剂，在5-HT（2B）受体上具有拮抗剂活性

• 5. HIGHLY SELECTIVE 5-HT(2C) RECEPTOR AGONISTS HAVING ANTAGONIST ACTIVITY AT THE 5-HT(2B) RECEPTOR [P] . CA2788416C . 2018-08-14

  机译： 具有高度选择性的5-HT（2C）受体激动剂，在5-HT（2B）受体上具有拮抗剂活性

• 1. Volatile anesthetics, enflurane, isoflurane inhibit 5-hydroxytryptamine type 2C receptors expressed in Xenopus oocytes [C] . Takafumi Horishita, Munehiro Shiraishi, Kouichiro Minam International Conference on Basic and Systemic Mechanisms of Anesthesia . 2005
• 2. A 5-HT locomotor system: Identification, actions through 5-HT(2A/7) receptor subtypes, and effects on the control of locomotion. [D] . Liu, Jun. 2007
• 3. We Need 2C but Not 2B: Developing Serotonin 2C (5-HT2C) Receptor Agonists for the Treatment of CNS Disorders [O] . Dr. Jianjun Cheng, Prof. Alan P. Kozikowski -1
• 4. (1R , 3 S )-(−)- Trans -PAT: A novel full-efficacy serotonin 5-HT 2C receptor agonist with 5-HT 2A and 5-HT 2B receptor inverse agonist/antagonist activity [O] . Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL 32610-0485, United States ( host institution ), Booth, Raymond G., Fang, Lijuan, 2009

• 1. 过氧化物酶体增殖物激活受体α亚型受体激动剂非诺贝特抗肿瘤作用的研究进展 [C] . 卢春兰 ,曾锦荣 . 第八届中国肿瘤内科大会、第三届中国肿瘤医师大会暨中国抗癌协会肿瘤临床化疗专业委员会2014年学术年会 . 2014
• 2. 5-羟色胺2A/2C受体激动剂DOI改善糖尿病大鼠排尿障碍的实验研究 [A] . 涂红坚 . 2014